BHT-3021

· Bayhill Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BHT-3021, covering 2011-06-28 to 2011-06-28. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study of BHT-3021 in Subjects With Type 1 Diabetes Mellitus [Phase 1]